| Brian Henry Lewis, DO | |
|
615 E Main St, Jenks, OK 74037-4138 | |
| (918) 299-8080 | |
| (918) 298-2838 |
| Full Name | Brian Henry Lewis |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 22 Years |
| Location | 615 E Main St, Jenks, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588748339 | NPI | - | NPPES |
| 7342704 | Other | OK | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 4091 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health | Bartlesville, OK | Home health agency |
| First Choice Hospice Ii | Sapulpa, OK | Hospice |
| Saint Francis Hospital, Inc | Tulsa, OK | Hospital |
| St John Medical Center, Inc | Tulsa, OK | Hospital |
| Baptist Village Of Owasso | Owasso, OK | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lewis And Wakefield Pllc | 8729020367 | 3 |
News Archive
The University of Kansas Cancer Center will present preclinical evidence supporting Ciclopirox Prodrug (CPX-POM), an anti-cancer agent currently in Phase I clinical trials, at the American Association for Cancer Research 2018 Annual Meeting in Chicago. Ciclopirox Prodrug was discovered by researchers at The University of Kansas Cancer Center and KU's Institute for Advancing Medical Innovation.
Computer simulations have been used with great success in recent months to visualize the spread of the COVID-19 virus in a variety of situations.
A state-of-the-art engineering approach toward improving the neutralizing activity of a cross-reactive nanobody, previously generated against the original SARS virus, showed it can be an attractive and viable option against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The study is published in the journal Advanced Therapeutics.
Chemotherapy is one of the primary treatments for cancer. However, one of the most disturbing findings of recent studies of cancer survivors is the apparent prevalence of chemotherapy-associated adverse neurological effects, including vascular complications, seizures, mood disorders, cognitive dysfunctions, and peripheral neuropathies.
› Verified 7 days ago
| Entity Name | Lewis & Wakefield Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962628339 PECOS PAC ID: 8729020367 Enrollment ID: O20050524001270 |
News Archive
The University of Kansas Cancer Center will present preclinical evidence supporting Ciclopirox Prodrug (CPX-POM), an anti-cancer agent currently in Phase I clinical trials, at the American Association for Cancer Research 2018 Annual Meeting in Chicago. Ciclopirox Prodrug was discovered by researchers at The University of Kansas Cancer Center and KU's Institute for Advancing Medical Innovation.
Computer simulations have been used with great success in recent months to visualize the spread of the COVID-19 virus in a variety of situations.
A state-of-the-art engineering approach toward improving the neutralizing activity of a cross-reactive nanobody, previously generated against the original SARS virus, showed it can be an attractive and viable option against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The study is published in the journal Advanced Therapeutics.
Chemotherapy is one of the primary treatments for cancer. However, one of the most disturbing findings of recent studies of cancer survivors is the apparent prevalence of chemotherapy-associated adverse neurological effects, including vascular complications, seizures, mood disorders, cognitive dysfunctions, and peripheral neuropathies.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian Henry Lewis, DO 615 E Main St, Jenks, OK 74037-4138 Ph: (918) 299-8080 | Brian Henry Lewis, DO 615 E Main St, Jenks, OK 74037-4138 Ph: (918) 299-8080 |
News Archive
The University of Kansas Cancer Center will present preclinical evidence supporting Ciclopirox Prodrug (CPX-POM), an anti-cancer agent currently in Phase I clinical trials, at the American Association for Cancer Research 2018 Annual Meeting in Chicago. Ciclopirox Prodrug was discovered by researchers at The University of Kansas Cancer Center and KU's Institute for Advancing Medical Innovation.
Computer simulations have been used with great success in recent months to visualize the spread of the COVID-19 virus in a variety of situations.
A state-of-the-art engineering approach toward improving the neutralizing activity of a cross-reactive nanobody, previously generated against the original SARS virus, showed it can be an attractive and viable option against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The study is published in the journal Advanced Therapeutics.
Chemotherapy is one of the primary treatments for cancer. However, one of the most disturbing findings of recent studies of cancer survivors is the apparent prevalence of chemotherapy-associated adverse neurological effects, including vascular complications, seizures, mood disorders, cognitive dysfunctions, and peripheral neuropathies.
› Verified 7 days ago
Dr. Nicole L Abel, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 2605 W Main St, Jenks, OK 74037 Phone: 918-298-2336 Fax: 918-298-2337 | |
Matthew Bryan Fowler, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 E Main St, Jenks, OK 74037 Phone: 918-298-2264 Fax: 918-298-0923 | |
Andrew Driscoll Donnelly, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 619 E Main St, Jenks, OK 74037 Phone: 918-299-8080 Fax: 918-298-2838 | |
Leah Upton, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 715 W Main St Suite S, Suite S, Jenks, OK 74037 Phone: 918-299-9447 Fax: 918-299-5325 | |
Dr. Paul A Waruszewski, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 715 W Main St, Suite S, Jenks, OK 74037 Phone: 918-299-9447 Fax: 918-299-5325 | |
Jeremy Ransdell, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 220 S Elm St, Jenks, OK 74037 Phone: 918-403-7144 Fax: 918-856-5561 | |
Dr. Sarah Renae Elneser, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 East Main Street, Jenks, OK 74037 Phone: 918-298-2264 Fax: 918-298-0923 |